|
NMT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48040000036431E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04239999965117E-08 |
| Normal-vs-Stage2 |
1.013260E-04 |
| Normal-vs-Stage3 |
3.779200E-01 |
| Normal-vs-Stage4 |
3.035200E-01 |
| Stage1-vs-Stage2 |
6.829200E-01 |
| Stage1-vs-Stage3 |
2.084500E-02 |
| Stage1-vs-Stage4 |
2.623800E-01 |
| Stage2-vs-Stage3 |
6.851800E-02 |
| Stage2-vs-Stage4 |
3.710000E-01 |
| Stage3-vs-Stage4 |
7.060600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20080000054479E-07 |
| Normal-vs-AfricanAmerican |
4.05599999999673E-05 |
| Normal-vs-Asian |
8.013000E-01 |
| Caucasian-vs-AfricanAmerican |
9.110200E-01 |
| Caucasian-vs-Asian |
4.287800E-01 |
| AfricanAmerican-vs-Asian |
4.434800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74419997836617E-09 |
| Normal-vs-Female |
3.658100E-02 |
| Male-vs-Female |
3.966100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.23950000002959E-06 |
| Normal-vs-Extreme_Weight |
5.88149999813936E-08 |
| Normal-vs-Obese |
3.435000E-04 |
| Normal-vs-Extreme_Obese |
1.95044999999894E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.925600E-01 |
| Normal_Weight-vs-Obese |
2.506400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.141200E-01 |
| Extreme_Weight-vs-Obese |
6.458000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.894600E-01 |
| Obese-vs-Extreme_Obese |
1.582170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.385600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.21219999999578E-05 |
| Normal-vs-Age(61-80Yrs) |
3.97379906758033E-11 |
| Normal-vs-Age(81-100Yrs) |
7.5678000000079E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.817700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.135650E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.580300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.879900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.628800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.876400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17730047932696E-10 |
| Normal-VS-Type2 PRCC |
2.37449999995754E-06 |
| Normal-VS-KIRP CIMP |
1.394640E-01 |
| Normal-VS-Unclassified PRCC |
1.246980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.310000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.818900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.366100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.180480E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.190000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.614010E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.34999999998631E-06 |
| Normal-vs-N1 |
7.432400E-01 |
| Normal-vs-N2 |
5.679000E-01 |
| N0-vs-N1 |
5.822100E-03 |
| N0-vs-N2 |
4.175600E-01 |
| N1-vs-N2 |
4.778600E-01 |
|
|
